Mourabit Halima, Author at MediaMedic

ASCO China Voice | Professor Jian Zhang: The First ADC Targeting Nectin-4, 9MW2821, Shows Promising Efficacy and Safety in Multiple Cancers

By Mourabit Halima 2025.03.05

Editor's Note: Nectin-4 has emerged as a highly expressed adhesion molecule in various solid tumors, becoming a popular target in recent research. 9MW2821, developed using an internationally leading ADC development…

EHA Expert Interview | Professor Zhiming Li: Zanubrutinib Combined with CHOP Shows Superior Efficacy in Newly Diagnosed DLBCL Patients, Especially in the GCB Subtype

By Mourabit Halima 2025.03.05

In the treatment of diffuse large B-cell lymphoma (DLBCL), the R-CHOP regimen has been a cornerstone, but enhancing its efficacy remains a significant challenge in the medical community. At the…

EHA Expert Interview | Professors Huilai Zhang and Shiyong Zhou’s Team: Major Advances in Lymphoma Research

By Mourabit Halima 2025.03.05

The 29th European Hematology Association (EHA) Annual Meeting was grandly held in Madrid, Spain, from June 13-16, 2024. As the largest international conference in the field of hematology in Europe,…

EHA Expert Interview | Professor Jie Jin: Zhejiang University’s Voice Resonates Internationally with GR1803 for RRMM

By Mourabit Halima 2025.03.05

The 29th European Hematology Association (EHA) Annual Meeting took place from June 13-16, 2024, in Madrid, Spain. As Europe's largest international event in the field of hematology, the meeting attracts…

Xinghai Forum: Professors Yang Zhang and Kejing Zhang Discuss CDK4/6 Inhibitors in Adjuvant Therapy for HR+ Breast Cancer

By Mourabit Halima 2025.03.05

Xinghai Forum: Professors Yang Zhang and Kejing Zhang Discuss CDK4/6 Inhibitors in Adjuvant Therapy for HR+ Breast Cancer Editor's Note: Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors have brought transformative breakthroughs to…

Posts by Mourabit Halima

ASCO China Voice | Professor Jian Zhang: The First ADC Targeting Nectin-4, 9MW2821, Shows Promising Efficacy and Safety in Multiple Cancers

EHA Expert Interview | Professor Zhiming Li: Zanubrutinib Combined with CHOP Shows Superior Efficacy in Newly Diagnosed DLBCL Patients, Especially in the GCB Subtype

EHA Expert Interview | Professors Huilai Zhang and Shiyong Zhou’s Team: Major Advances in Lymphoma Research

EHA Expert Interview | Professor Jie Jin: Zhejiang University’s Voice Resonates Internationally with GR1803 for RRMM

Xinghai Forum: Professors Yang Zhang and Kejing Zhang Discuss CDK4/6 Inhibitors in Adjuvant Therapy for HR+ Breast Cancer

HNF1A Genotype & HCC Risk | Dr. Mohamed Abdel Samiee

EASL Liver Cancer Summit 2025 | Professor Abdel Ghani Badran on Ultrasound Elastography for Early HCC Detection

EHA 2024: Transforming Insights into Action for Better Patient Outcomes

EHA 2024: Bridging Research and Practice to Elevate Hematology Care

A Doctor’s Battle Against Cancer: A Story of Hope and Innovation